Health Trials

Non-familial Hypercholesterolemia and Mixed Hyperlipidemia

2

Review clinical trials related to Non-familial Hypercholesterolemia and Mixed Hyperlipidemia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholesterolemia or Mixed Hyperlipidemia

The purpose of this study is to evaluate the efficacy and safety of SYH2053 monotherapy in patients with primary hypercholesterolemia (non-familial) or mixed dyslipidemia . This trial plans to enroll 760 Participants.

Participants needed: 760
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.Updated: Apr 7, 2026Locations: 2
Eligibility criteria

、Age ≥18 years (inclusive); [+1]

Prior diagnosis of familial hypercholesterolemia; or a history of the following... [+15]

Read more
Status: Not yet recruiting

A Study to Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia on a Background of Lipid-lowering Therapy

The purpose of this study is to compare the effectiveness, safety of SYH2053 in participants with primary hypercholesterolemia (non-familial) or mixed dyslipidemia on a background of lipid-lowering therapy. This trial plans to enroll 900 Participants.

Participants needed: 900
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.Updated: Feb 19, 2026Locations: 1
Eligibility criteria

Age of 18 - 75 years (inclusive); [+5]

Prior diagnosis of familial hypercholesterolemia; or a history of the following... [+14]

Read more